Hancock Whitney Corp Pacira Bio Sciences, Inc. Transaction History

Hancock Whitney Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 13, 2023	SELL	$35.53 - $43.38 $26,860 - $32,795	-756 Reduced 11.87%	5,615 $229,000
Q1 2023 May 16, 2023	SELL	$35.53 - $43.38 $26,860 - $32,795	-756 Reduced 11.87%	5,615 $229,000
Q4 2022 Nov 13, 2023	BUY	$38.19 - $57.45 $243,308 - $366,013	6,371 New	6,371 $245,000
Q4 2022 Feb 03, 2023	SELL	$38.19 - $57.45 $2,864 - $4,308	-75 Reduced 1.16%	6,371 $246,000
Q3 2022 Oct 26, 2022	BUY	$51.24 - $58.89 $48,370 - $55,592	944 Added 17.16%	6,446 $343,000
Q2 2022 Aug 08, 2022	SELL	$51.49 - $81.64 $11,997 - $19,022	-233 Reduced 4.06%	5,502 $321,000
Q1 2022 May 12, 2022	SELL	$60.03 - $76.49 $76,298 - $97,218	-1,271 Reduced 18.14%	5,735 $438,000
Q4 2021 Jan 25, 2022	SELL	$47.97 - $62.21 $2,446 - $3,172	-51 Reduced 0.72%	7,006 $422,000
Q3 2021 Nov 04, 2021	BUY	$54.64 - $61.3 $2,240 - $2,513	41 Added 0.58%	7,057 $395,000
Q2 2021 Aug 09, 2021	SELL	$59.18 - $69.99 $8,877 - $10,498	-150 Reduced 2.09%	7,016 $426,000
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $6,879 - $9,143	-116 Reduced 1.59%	7,166 $502,000
Q4 2020 Feb 09, 2021	SELL	$50.47 - $66.26 $1,362 - $1,789	-27 Reduced 0.37%	7,282 $436,000
Q3 2020 Nov 05, 2020	BUY	$51.97 - $63.0 $14,811 - $17,955	285 Added 4.06%	7,309 $439,000
Q2 2020 Jul 30, 2020	SELL	$30.8 - $52.47 $80,850 - $137,733	-2,625 Reduced 27.2%	7,024 $369,000
Q1 2020 May 08, 2020	BUY	$28.4 - $50.7 $274,031 - $489,204	9,649 New	9,649 $324,000

266

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $761M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.